Fidelity International’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Fidelity International’s Portfolio DSCI Stock Details DSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-310,987	Closed	-$1.42M	–	539
2015 Q4	$1.42M	Hold	310,987	–	–	﹤0.01%	448
2015 Q3	$1.47M	Hold	310,987	–	–	0.01%	456
2015 Q2	$2.23M	Buy	310,987 +141,491	+83%	+$1.06M	0.01%	464
2015 Q1	$1.44M	Hold	169,496	–	–	﹤0.01%	467
2014 Q4	$1.58M	Hold	169,496	–	–	0.01%	449
2014 Q3	$1.41M	Buy	169,496 +100,084	+144%	+$927K	0.01%	447
2014 Q2	$802K	Buy	+69,412	New	+$712K	﹤0.01%	472

Other funds holding DSCI

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Fidelity International's DSCI Position: Q1 2016 in Review

Fidelity International sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q1 2016, closing a stake of 310,987 shares — an estimated $1.42M sold.

Fidelity International first reported a position in DSCI in Q2 2014 and held it in 7 quarters. The position peaked at $2.23M in Q2 2015. 55 funds tracked by Wall St. Rank hold DSCI as of Q1 2016.

Fidelity International reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q1 2016 after selling out during the quarter.
Fidelity International sold 310,987 Derma Sciences, Inc. Common Stock (DE) shares in Q1 2016, an estimated $1.42M.
Fidelity International first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q2 2014 and held it in 7 quarters.
Fidelity International's Derma Sciences, Inc. Common Stock (DE) position peaked at $2.23M in Q2 2015.
55 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q1 2016.

Based on Fidelity International's 13F filing for Q1 2016, filed 16 May 2016.